COVID Vaccine Equity Research Dialogues (CoVEReD): Newsletters
As the rollout of the U.S. COVID-19 vaccine program continues and questions remain about how allocation can simultaneously reduce risk and inequity, Penn LDI is convening a new series, COVID Vaccine Equity Research Dialogues (CoVEReD). Hosted by Penn LDI Senior Fellows and vaccine policy experts Alison Buttenheim, PhD, MBA, and Harald Schmidt, PhD, MA, the series brings together top experts to discuss equitable vaccine distribution. See the latest CoVEReD newsletters and videos below, and be sure to subscribe to receive future editions.
Can we Overcome Vaccine Barriers for Immigrants in the U.S.—And Improve Access Globally?
Featuring Rebecca Weintraub, MD, Harvard Medical School (May 4, 2021)
When Everyone's Eligible, What Happens to Vaccine Equity?
Featuring Jennifer Tolbert, MPH, MSW, Kaiser Family Foundation (April 21, 2021)
Should Vaccine Allocation Be Increased Where Cases Are Rising and Decreased Where Demand is Low?
Featuring Paul Delamater, PhD, University of North Carolina, Chapel Hill (April 6, 2021)
What Does President’s May 1 Deadline for Universal Eligibility Mean for Vaccine Equity?
Featuring Angela Shen, ScD, MPH, Vaccine Education Center, Children’s Hospital of Philadelphia (March 23, 2021)
Should We Use Disadvantage Indices to Allocate Vaccine Doses?
Featuring Susan Goold, MD, MHSA, MA, Institute for Healthcare Policy and Innovation, University of Michigan (February 24, 2021)